Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 250 clinical trials
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Background Glioblastoma is a type of brain cancer. Treatments include radiation, chemotherapy, and surgery. But survival rates are poor. Researchers think that the drug selinexor, when combined with chemotherapy and radiation, might help. Objective To learn the highest dose of selinexor that people with brain cancer can tolerate when given …

brain tumor
platelet count
gliosarcoma
therapeutic agent
neutrophil count
  • 0 views
  • 19 Feb, 2024
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow …

investigational drug
meningiomatosis
brigatinib
experimental drug
ependymoma
  • 0 views
  • 19 Feb, 2024
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

recurrent thyroid gland carcinoma
chemotherapeutic agents
recurrent hepatoblastoma
medulloblastoma recurrent
antineoplastic
  • 0 views
  • 19 Feb, 2024
Niraparib/TTFields in GBM

Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).

renal function test
tumor treating fields therapy
recurrent glioblastoma
glioblastoma
niraparib
  • 0 views
  • 19 Feb, 2024
Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices in patients with recurrent gliomas whose are treated with Apatinib, for evaluating the efficacy and safety of Apatinib. Moreover, by leveraging artificial intelligence, this study …

platelet count
apatinib
tyrosine
neutrophil count
vascular endothelial growth factor receptor 2
  • 0 views
  • 19 Feb, 2024
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence

This registry aims to collect clinical, molecular and radiologic data including detailed survival data, clinical parameters, molecular pathology (1p/19q codeletion, MGMT methylation, IDH and TERTp mutations, etc) and conventional/advanced/new MR sequences (T1, T1c, T2, FLAIR, ADC, DTI, PWI, etc) of patients with primary gliomas. By leveraging artificial intelligence, this registry …

glioma
tumor resection
tumour resection
flair
molecular pathology
  • 0 views
  • 19 Feb, 2024
Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence

This registry aims to collect clinical, molecular and histopathology imaging including detailed survival data, clinical parameters, molecular pathology (1p/19q codeletion, MGMT methylation, IDH and TERTp mutations, etc) and images of HE slices in primary gliomas. By leveraging artificial intelligence, this registry will seek to construct and refine hstopathology imaging based …

glioma
tumor resection
tumour resection
molecular pathology
  • 0 views
  • 19 Feb, 2024
MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

This registry aims to collect clinical, molecular and radiologic data including detailed clinical parameters, molecular pathology (1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations, etc) and conventional/advanced/new MR sequences (T1, T1c, T2, FLAIR, ADC, DTI, PWI, etc) of patients with primary gliomas. By leveraging artificial intelligence, this registry will seek …

glioma
tumor resection
tumour resection
flair
molecular pathology
  • 0 views
  • 19 Feb, 2024
Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

This registry aims to collect clinical, molecular and radiologic data including detailed clinical parameters, molecular pathology (1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations, etc) and images of HE slices in primary gliomas. By leveraging artificial intelligence, this registry will seek to construct and refine histopathology image based algorithms that …

glioma
tumor resection
tumour resection
molecular pathology
  • 0 views
  • 19 Feb, 2024
Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

This study seeks to find the prognostic and clinical significance based on molecular and genetic biomarkers/subgroups of gliomas.

glioma
tumor resection
tumour resection
intracranial glioma
molecular pathology
  • 0 views
  • 19 Feb, 2024